Register to hear Professor Robyn Guymer AM present: “How will we know when we are there?”: How to prove a treatment for macular degeneration is actually effective.
Our new Consumer Program is working alongside people with lived experience to ensure their insights are at the heart of advancing eye research.
Learn about the program and meet our Consumer Advisory Group.
In a world first, scientists at CERA have used tiny particles derived from blood to provide first-line treatment for corneal injuries in lab experiments.
A CERA and University of Melbourne project is looking for volunteers to help understand the impact of vision loss to improve how the success of new therapies are measured.
CERA’s Consumer Advisory Group member Dr Colleen Lewis shares how meeting consumers at their level left an impact on her at the Australian Clinical Trials Alliance conference.
New research examines the benefits of using AI retinal imaging to screen for cardiovascular disease in GP clinics, and identifies areas for improvement.
